K F Hossack
Overview
Explore the profile of K F Hossack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Percutaneous transluminal coronary angioplasty: clinical and quality of life outcomes one year later
McKenna K, McEniery P, Maas F, Aroney C, Bett J, Cameron J, et al.
Aust N Z J Med
. 1994 Feb;
24(1):15-21.
PMID: 8002852
Background: The quality of life status of patients prior to and following percutaneous transluminal coronary angioplasty (PTCA) has not been comprehensively investigated. Aim: This study was carried out to determine...
2.
McKenna K, McEniery P, Maas F, Aroney C, Bett J, Cameron J, et al.
Cathet Cardiovasc Diagn
. 1992 Oct;
27(2):89-94.
PMID: 1446341
To evaluate the effect of percutaneous transluminal coronary angioplasty (PTCA) on quality of life, data on symptomatic status, functional capacity, life satisfaction, and psychological wellness were collected on 102 patients...
3.
Narahara K, Singh B, Karliner J, Corday S, Hossack K
Am J Cardiol
. 1992 Apr;
69(11):37D-42D.
PMID: 1553890
Bepridil is a calcium antagonist with a unique chemical composition and a long elimination half-life (42 hours). We evaluated the efficacy of bepridil 300 mg once/day in a crossover comparison...
4.
Earnest M, Thomas G, Eden R, Hossack K
Epilepsia
. 1992 Mar;
33(2):310-6.
PMID: 1547760
Sudden unexplained death syndrome (SUDS) accounts for about 10% of deaths in patients with epilepsy. It is associated with subtherapeutic postmortem serum antiepileptic drug (AED) levels but no anatomic cause...
5.
Lewis F, Adair O, Hossack K, Everson G, White J, Rector Jr W
J Lab Clin Med
. 1991 Jan;
117(1):67-75.
PMID: 1987311
We tested the hypothesis that increased plasma glucagon concentration resulting from portal-systemic shunting or liver dysfunction causes arterial vasodilation and thereby stimulates sodium retention in cirrhosis. Twenty-seven studies were performed...
6.
Rector Jr W, Adair O, Hossack K, Rainguet S
Gastroenterology
. 1990 Sep;
99(3):766-70.
PMID: 2143159
Increased blood volume, atrial size, and plasma concentration of atrial natriuretic factor are described in cirrhosis. Their interrelationships were examined in 17 men with alcoholic liver disease, 7 with and...
7.
Rector Jr W, Hossack K, Ready J
J Hepatol
. 1990 May;
10(3):375-80.
PMID: 2114438
Nitroglycerin is reportedly an effective treatment for portal hypertension. However, the effects of graded doses have not been examined. We administered nitroglycerin intravenously to 10 patients with alcoholic cirrhosis, beginning...
8.
Ready J, Hossack K, Rector Jr W
Hepatology
. 1990 Apr;
11(4):674-7.
PMID: 2328959
The pathogenesis of variceal hemorrhage is not well understood. Portal pressure and gastroesophageal collateral (azygous) blood flow are similar in patients with cirrhosis with or without a history of variceal...
9.
Hossack K, Adair O, Crowley S
Cardiology
. 1990 Jan;
77(6):433-42.
PMID: 2150010
In an attempt to determine factors that are related to atrial natriuretic factor (ANF) release in normal subjects, 10 male volunteers were studied at rest supine, sitting and during treadmill...
10.
Kinnard D, Harris M, Hossack K
Am Heart J
. 1989 Nov;
118(5 Pt 2):1136.
PMID: 2530877
No abstract available.